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Background
HIV and SIV pathogenic infection is characterized by early
CD4+ T cell dysfunction.
Methods
Using a protocol of optimized in vitro expansion of
enriched CD4+ T cells, we have been able to induce long-
term control of viremia in rhesus macaques chronically
infected with SIVmac239.
Results
Antiviral control was characterized with the extended
presence multifunctional antigen specific CD4 and CD8+
T cells detected even 1 year post transfer while viral loads
remained mostly undetectable. Monitoring of trafficking
and turnover of adoptively transferred anti-CD3/28
expanded CFSE labeled CD4+ T cells demonstrated exten-
sive recirculation and dissemination of these cells with
relatively slow homeostatic proliferation over time and
long time engraftment in LTNP monkeys. In efforts to
examine the long-term contribution of adoptively trans-
ferred anti-CD3/28 expanded CD4+ T cells, another set of
monkeys was treated with transduced with a retroviral
vector directing intracellular expression of the HSV-tk sui-
cide gene and the extracellular expression of the nerve
growth factor receptor (NGFR). Transduced cells enriched
based on NGFR expression were expanded with anti-CD3/
28 coated beads and transfused in SIV infected monkeys
under short term ART. Two weeks following the last adop-
tive transfer, the transferred cells were selectively elimi-
nated by ganciclovir administration, resulting in various
levels of viral rebound after initial control. The data lends
support to a long term therapeutic effect of adoptively
transferred in vitro expanded CD4+ T cells even in the
absence of transduction of antiviral moiety, these cells
appear refractory to SIV production, for at least 2 weeks
post expansion.
Conclusion
Thus, we demonstrate that partial replenishment of the
CD4 (unsorted) compartment is sufficient to induce
potent immune mediated control of viremia during SIV
infection.
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